Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI USA – English
Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights, announced today that it has raised $34 million in Series B financing. This additional funding...

